Asset Management
Compare Stocks
2 / 10Stock Comparison
IVZ vs VRTS
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
IVZ vs VRTS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Asset Management | Asset Management |
| Market Cap | $12.15B | $960M |
| Revenue (TTM) | $6.38B | $831M |
| Net Income (TTM) | $-243M | $138M |
| Gross Margin | 43.2% | 74.9% |
| Operating Margin | -10.9% | 17.4% |
| Forward P/E | 10.6x | 5.6x |
| Total Debt | $10.12B | $2.84B |
| Cash & Equiv. | $1.98B | $477M |
IVZ vs VRTS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Invesco Ltd. (IVZ) | 100 | 343.2 | +243.2% |
| Virtus Investment P… (VRTS) | 100 | 154.2 | +54.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IVZ vs VRTS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IVZ carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 5.1%, EPS growth -235.6%
- Lower volatility, beta 1.67, Low D/E 77.9%, current ratio 43.01x
- 5.1% NII/revenue growth vs VRTS's -8.0%
VRTS is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 7 yrs, beta 1.14, yield 6.5%
- 159.1% 10Y total return vs IVZ's 23.3%
- Beta 1.14, yield 6.5%, current ratio 3.80x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.1% NII/revenue growth vs VRTS's -8.0% | |
| Value | Lower P/E (5.6x vs 10.6x) | |
| Quality / Margins | Efficiency ratio 0.5% vs VRTS's 0.6% (lower = leaner) | |
| Stability / Safety | Beta 1.14 vs IVZ's 1.67 | |
| Dividends | 6.5% yield, 7-year raise streak, vs IVZ's 3.0% | |
| Momentum (1Y) | +98.8% vs VRTS's -4.2% | |
| Efficiency (ROA) | Efficiency ratio 0.5% vs VRTS's 0.6% |
IVZ vs VRTS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IVZ vs VRTS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
VRTS leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
IVZ is the larger business by revenue, generating $6.4B annually — 7.7x VRTS's $831M. VRTS is the more profitable business, keeping 16.7% of every revenue dollar as net income compared to IVZ's -4.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $6.4B | $831M |
| EBITDAEarnings before interest/tax | $1.2B | $205M |
| Net IncomeAfter-tax profit | -$243M | $138M |
| Free Cash FlowCash after capex | $1.9B | -$67M |
| Gross MarginGross profit ÷ Revenue | +43.2% | +74.9% |
| Operating MarginEBIT ÷ Revenue | -10.9% | +17.4% |
| Net MarginNet income ÷ Revenue | -4.4% | +16.7% |
| FCF MarginFCF ÷ Revenue | +22.6% | -8.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +34.2% | +10.9% |
Valuation Metrics
VRTS leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, VRTS's 16.3x EV/EBITDA is more attractive than IVZ's 16.5x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $12.2B | $960M |
| Enterprise ValueMkt cap + debt − cash | $20.3B | $3.3B |
| Trailing P/EPrice ÷ TTM EPS | -17.09x | 7.18x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.64x | 5.61x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.49x |
| EV / EBITDAEnterprise value multiple | 16.53x | 16.25x |
| Price / SalesMarket cap ÷ Revenue | 1.91x | 1.16x |
| Price / BookPrice ÷ Book value/share | 0.95x | 0.96x |
| Price / FCFMarket cap ÷ FCF | 8.43x | — |
Profitability & Efficiency
VRTS leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
VRTS delivers a 13.5% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-2 for IVZ. IVZ carries lower financial leverage with a 0.78x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRTS's 2.74x. On the Piotroski fundamental quality scale (0–9), IVZ scores 6/9 vs VRTS's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -1.7% | +13.5% |
| ROA (TTM)Return on assets | -0.9% | +3.6% |
| ROICReturn on invested capital | -2.3% | +3.0% |
| ROCEReturn on capital employed | -2.6% | +3.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.78x | 2.74x |
| Net DebtTotal debt minus cash | $8.1B | $2.4B |
| Cash & Equiv.Liquid assets | $2.0B | $477M |
| Total DebtShort + long-term debt | $10.1B | $2.8B |
| Interest CoverageEBIT ÷ Interest expense | -6.19x | 2.15x |
Total Returns (Dividends Reinvested)
IVZ leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IVZ five years ago would be worth $11,058 today (with dividends reinvested), compared to $6,525 for VRTS. Over the past 12 months, IVZ leads with a +98.8% total return vs VRTS's -4.2%. The 3-year compound annual growth rate (CAGR) favors IVZ at 22.3% vs VRTS's 0.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +2.3% | -8.8% |
| 1-Year ReturnPast 12 months | +98.8% | -4.2% |
| 3-Year ReturnCumulative with dividends | +83.0% | +1.1% |
| 5-Year ReturnCumulative with dividends | +10.6% | -34.8% |
| 10-Year ReturnCumulative with dividends | +23.3% | +159.1% |
| CAGR (3Y)Annualised 3-year return | +22.3% | +0.4% |
Risk & Volatility
Evenly matched — IVZ and VRTS each lead in 1 of 2 comparable metrics.
Risk & Volatility
VRTS is the less volatile stock with a 1.14 beta — it tends to amplify market swings less than IVZ's 1.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IVZ currently trades 92.4% from its 52-week high vs VRTS's 66.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.67x | 1.14x |
| 52-Week HighHighest price in past year | $29.61 | $215.06 |
| 52-Week LowLowest price in past year | $14.04 | $121.61 |
| % of 52W HighCurrent price vs 52-week peak | +92.4% | +66.7% |
| RSI (14)Momentum oscillator 0–100 | 66.3 | 55.1 |
| Avg Volume (50D)Average daily shares traded | 5.1M | 100K |
Analyst Outlook
VRTS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates IVZ as "Hold" and VRTS as "Hold". Consensus price targets imply 13.7% upside for VRTS (target: $163) vs 8.7% for IVZ (target: $30). For income investors, VRTS offers the higher dividend yield at 6.50% vs IVZ's 3.04%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $29.72 | $163.00 |
| # AnalystsCovering analysts | 28 | 11 |
| Dividend YieldAnnual dividend ÷ price | +3.0% | +6.5% |
| Dividend StreakConsecutive years of raises | 4 | 7 |
| Dividend / ShareAnnual DPS | $0.83 | $9.32 |
| Buyback YieldShare repurchases ÷ mkt cap | +15.3% | +6.2% |
VRTS leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). IVZ leads in 1 (Total Returns). 1 tied.
IVZ vs VRTS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is IVZ or VRTS a better buy right now?
For growth investors, Invesco Ltd.
(IVZ) is the stronger pick with 5. 1% revenue growth year-over-year, versus -8. 0% for Virtus Investment Partners, Inc. (VRTS). Virtus Investment Partners, Inc. (VRTS) offers the better valuation at 7. 2x trailing P/E (5. 6x forward), making it the more compelling value choice. Analysts rate Invesco Ltd. (IVZ) a "Hold" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IVZ or VRTS?
On forward P/E, Virtus Investment Partners, Inc.
is actually cheaper at 5. 6x.
03Which is the better long-term investment — IVZ or VRTS?
Over the past 5 years, Invesco Ltd.
(IVZ) delivered a total return of +10. 6%, compared to -34. 8% for Virtus Investment Partners, Inc. (VRTS). Over 10 years, the gap is even starker: VRTS returned +159. 1% versus IVZ's +23. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IVZ or VRTS?
By beta (market sensitivity over 5 years), Virtus Investment Partners, Inc.
(VRTS) is the lower-risk stock at 1. 14β versus Invesco Ltd. 's 1. 67β — meaning IVZ is approximately 47% more volatile than VRTS relative to the S&P 500. On balance sheet safety, Invesco Ltd. (IVZ) carries a lower debt/equity ratio of 78% versus 3% for Virtus Investment Partners, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IVZ or VRTS?
By revenue growth (latest reported year), Invesco Ltd.
(IVZ) is pulling ahead at 5. 1% versus -8. 0% for Virtus Investment Partners, Inc. (VRTS). On earnings-per-share growth, the picture is similar: Virtus Investment Partners, Inc. grew EPS 18. 2% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IVZ or VRTS?
Virtus Investment Partners, Inc.
(VRTS) is the more profitable company, earning 16. 7% net margin versus -4. 4% for Invesco Ltd. — meaning it keeps 16. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VRTS leads at 17. 4% versus -10. 9% for IVZ. At the gross margin level — before operating expenses — VRTS leads at 74. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IVZ or VRTS more undervalued right now?
On forward earnings alone, Virtus Investment Partners, Inc.
(VRTS) trades at 5. 6x forward P/E versus 10. 6x for Invesco Ltd. — 5. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRTS: 13. 7% to $163. 00.
08Which pays a better dividend — IVZ or VRTS?
All stocks in this comparison pay dividends.
Virtus Investment Partners, Inc. (VRTS) offers the highest yield at 6. 5%, versus 3. 0% for Invesco Ltd. (IVZ).
09Is IVZ or VRTS better for a retirement portfolio?
For long-horizon retirement investors, Virtus Investment Partners, Inc.
(VRTS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 14), 6. 5% yield, +159. 1% 10Y return). Invesco Ltd. (IVZ) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VRTS: +159. 1%, IVZ: +23. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IVZ and VRTS?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IVZ is a mid-cap income-oriented stock; VRTS is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.